Please click below for Niche Technologies
Arch Facilities across India
Company Profile
Pharmaceutical product development and commercialization is a highly expensive and lengthy process. Arch Pharmalabs Limited is a top-tier, India-based API player. We provide the global drug industry with a powerful competitive edge through innovative, quality-focused, timely and cost-advantaged process R&D and manufacturing solutions across branded and generic product life cycles. The Company has two state-of-the-art Process Technology centres, eleven cGMP and ISO-certified sites (including US FDA, EDQM and TGA inspected facilities) and 2,500 people in India. Maintaining a unique position as a non-competing supplier, Arch Pharmalabs' customer-centric, IP-secure service and product offering includes:
- Process R&D, exclusive synthesis of drug intermediates and active ingredients to enable pre-clinical studies, Phase I-III clinical trials, validation / launch planning and life cycle management for global innovators.
- Manufacture and supply of a wide range of generic APIs and intermediates for a worldwide client base.
- Comprehensive QA & Regulatory support.
A key component of Arch Pharmalabs' growth strategy is to access superior chemical technologies to help its customers develop newer, better and value-enhanced products. Notable examples include High-Potency Drug Manufacturing and SMB Separations. With annual revenues of USD 200 million, Arch Pharmalabs has experienced robust financial growth since inception in 1999, while exceeding its customers' expectations. Arch Pharmalabs (USA) Inc. is the company's US subsidiary and spearheads strategic alliance, commercial and marketing initiatives in North America.
